Repligen to buy BioLife in $1.5 billion deal to expand cell therapy business

This is a summary. Read the complete story at Investing.com below.

Related Stories

stocksabout 4 hours ago

US judge signals rejection of part of TikTok privacy settlement

Investing.com

stocksabout 6 hours ago

Porsche could face another 4,000 job cuts, Handelsblatt reports

Investing.com

stocksabout 8 hours ago

Ten days that changed the course of AI

Investing.com